Riederer, A <br/><br/>
Effect of the Glucagon-like Peptide-1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus.  [electronic resource] 

 -  Journal of veterinary internal medicine   
 - 92-100 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1939-1676 
<br/><br/><label>Standard No.: </label>10.1111/jvim.13817  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animal Feed--analysis<br/>Animals<br/>Blood Glucose<br/>Cat Diseases--drug therapy<br/>Cats<br/>Diabetes Mellitus--drug therapy<br/>Diet--veterinary<br/>Dietary Carbohydrates--pharmacology<br/>Exenatide<br/>Female<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--adverse effects<br/>Insulin Glargine--therapeutic use<br/>Male<br/>Peptides--adverse effects<br/>Venoms--adverse effects